OWC Pharmaceutical Research Corp (OWCP)

[moxa1]

OWCP is indeed making pharmaceutical grade products that are in the process of being rigorously tested for both safety and effectiveness. The Phase I efficacy trial for the cream was completed last year and showed a greater than 70% improvement in inflammatory markers for psoriasis. Phase II trials will be underway shortly. In the meantime IRB safety trials are due for completion this quarter. After that I believe the CanaPsor cream will be a candidate for marketing and distribution by any number of pharma companies wishing to enter the medical cannabis space. A JV/partnership/licensing deal is something that investors hope will happen after the completion. Publication of the results would be icing on the cake and I personally hope they will do this for added legitimacy amongst the pharma community.

To my knowledge no one else in this space has put their products through such rigorous testing. Corrections welcome.